Clinical trial · Observational
Patient Registry: Partial Breast Irradiation
Patient Registry: A Study of the Use of Accelerated Partial Breast Irradiation to Evaluate Local Tumor Control, Cosmetic Outcome and Toxicities
NCT01127971CI-TRIAL-00081299PBI RegistryterminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): administrative reasons (no impact/concern of subject rights, welfare, safety)
Summary
Brief summary (as posted)
This is an Aurora Health Care system registry of patients receiving accelerated partial breast irradiation and external beam.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The collection and analysis of sufficient data to determine 5 and 10-year local recurrence rates is collection and analysis of sufficient data to determine 5 and 10-year local recurrence rates
- timeFrame
- 5 and 10-year local recurrence rates
- description
- The primary endpoint of this registry trial is collection and analysis of sufficient data to determine 5 and 10-year local recurrence rates for each PBI type used and for the overall Aurora population. The following endpoints will also be reported and analyzed: * Disease Free Survival * Regional Recurrence * Distant Metastasis * Combined Recurrence
Secondary outcomes (1)
- measure
- collection and analysis of data to evaluate and compare cosmetic outcome
- timeFrame
- 5 and 10-year
- description
- The secondary endpoint is the collection and analysis of data to evaluate and compare cosmetic outcome (per Harvard Score) and toxicities/complications for each PBI type (per Common Terminology Criteria for Adverse Events (referred to as CTC or CTCAE))
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: * Aurora patients who decide to undergo PBI treatment in the next 5-years or who have had PBI Treatment in the last ten-years. All such patients are female. Exclusion Criteria: * Patients not seen in an Aurora facility
References
Publications (0)
Data not yet available
No reference posted for this study.